A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer
Eisai Inc. · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011